Home Tags 177Lu-PSMA-617

Tag: 177Lu-PSMA-617

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Novartis announced that it has entered into an agreement and plan of merger with Endocyte, a US-based biopharmaceutical company focused on developing targeted therapeutics...

Market Trend: Cancer Immunotherapy Destined for Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14 billion by 2022, growing at...

FEATURED RESOURCES